Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYTĀ® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

Events and presentations

Events and presentations

Upcoming events

Please visit Publications & Presentations to find our most recent data presentations.